Hacker Newsnew | past | comments | ask | show | jobs | submit | Cipater's commentslogin

I had a similar experience trying out Gemini early this year where it would always say it couldn't do the thing I asked but could provide resources and/or walk me through doing the thing myself.


From the article:

>Silicon Valley’s militarization is in many ways a return to the region’s roots.

>Before the area was a tech epicenter, it was a bucolic land of fruit orchards. In the 1950s, the Defense Department began investing in tech companies in the region, aiming to compete with Russia’s technological advantages in the Cold War. That made the federal government the first major backer of Silicon Valley.

>The Defense Advanced Research Projects Agency, a division of the Department of Defense, later incubated technology — such as the internet — that became the basis for Silicon Valley’s largest companies. In 1998, the Stanford graduate students Sergey Brin and Larry Page received funding from Darpa and other government agencies to create Google.


The 3rd generation iPhone SE was released in 2022.


Both iPhone SE (3rd generation) [2022] and iPhone SE (2nd generation) [2020] support iOS 18.6.

So that commenter must not have those generations and your comment doesn't help.

iPhone SE (1st generation) [2016] is stuck on iOS 15 but still receiving security updates, like 15.8.4 from the spring.


the 2022 iPhone SE supports iOS 18


Thank you for teaching me a new word.

Prolixity - unnecessarily or tediously wordy


I prefer the almost comical sounding word, logorrhea.


The FDA approved an average of 47 new drugs annually from 2015 to 2024.

A few notables.

Ekterly (sebetralstat) – Treats hereditary angioedema (approved July 3, 2025)

Zegfrovy (sunvozertinib) – For NSCLC with EGFR exon-20 insertion mutations (July 2, 2025)

Widaplik (amlodipine + indapamide + telmisartan) – Single-pill hypertension therapy (June 5, 2025)

Tryptyr (acoltremon ophthalmic) – First in class dry-eye treatment (May 28, 2025)

mNEXSPIKE – Next-gen Moderna mRNA COVID-19 vaccine (May 30, 2025)

Emrelis (telisotuzumab vedotin) – Lung cancer (NSCLC) targeted therapy (May 14, 2025)

Yutrepia (treprostinil inhalation) – For pulmonary arterial hypertension (May 23, 2025)

Brekiya (dihydroergotamine autoinjector) – Acute migraine and cluster headache therapy (May 14, 2025)

Gomekli, Journavx, Grafapex, Datroway – Novel agents in oncology and pain management (early 2025)

Opzelura (ruxolitinib cream) – For vitiligo and atopic dermatitis (2022–2023)

Cobenfy (KarXT) – New schizophrenia medication targeting cholinergic receptors (Sept 2024)

Tarlatamab (Imdelltra) – First in class BiTE immunotherapy for small-cell lung cancer (May 2024)

Pegcetacoplan (Empaveli/Syfovre) – First complement C3 inhibitor for PNH & geographic atrophy (May 2021)

Leniolisib (Joenja) – First treatment for APDS immune deficiency (March 2023)

Nedosiran (Rivfloza) – siRNA therapy for primary hyperoxaluria (Sept 2023)

Retifanlimab (Zynyz) – PD-1 antibody for Merkel cell carcinoma (March 2023)

Are you aware of any of these?


>was all the time you had to spend classifying each engineer's time spent as R&D or 'internal software'

> every year, me and my engineering lead counterparts would spend almost a day

This is quite funny. Not even a day, almost one.


There is now a notice on each and every US Embassy website visa home page that says:

Effective immediately, all individuals applying for an F, M, or J nonimmigrant visa are requested to adjust the privacy settings on all of their social media accounts to ‘public’ to facilitate vetting necessary to establish their identity and admissibility to the United States under U.S. law.

Pick any at random to verify.


Hat tip: Great follow-up. I asked Google AI about those visa types and it told me:

    > F, M, and J visas are all nonimmigrant visas for foreign nationals seeking to study or participate in exchange programs in the United States.
Tangent: US must have 5x the number of visa types compared to most other highly developed nations. Whenever there is a US visa discussion on HN, I always learn about a few more types! Plus they have all sorts of weird carve-outs for various nations: Looking at you Australia and Singapore.


The idea that more diverse leadership leads to better outcomes doesn't mean women are incapable of wrongdoing. Nobody said women are perfect angels who can do no wrong. That's a strawman and you know it.

Be better, come on.


> Be better, come on.

I am male. I can't "be better", I am already "the problem". Which is a reason why I am so fed up be the fight of the sexes. Its overboarding accusations on all sides. And I am not willing to "turn the other cheek" anymore.

> Nobody said women are perfect angels who can do no wrong

Ahem, the "believe all women" crowd did and do.


> I am male. I can't "be better", I am already "the problem".

Whether you are the problem or not is unrelated to your maleness. Being willing to be and do better is the first step on the journey that enables you to realise that truth.


Less of this culture-war nonsense here, please. Especially in a thread about something completely unrelated. (No, the fact that the exec in question is female doesn't make it related. If they'd been male then someone could equally-relevantly make the argument "see, this shows that we need more women in leadership".)


Isn't it YouTube that decides whether to serve pre-roll ads?


Surely this is untrue?

Isn't it the opposite? What are you basing this on?

https://www.theguardian.com/us-news/2025/apr/01/billionaires...

https://americansfortaxfairness.org/billionaires-buying-elec...

Billionaire spending heavily favored Republicans. Over two-thirds (70%) of billionaire-family contributions went in support of GOP candidates and conservative causes. Less than a quarter (23%) backed Democratic hopefuls and progressive causes. (The remainder went to committees without a clear partisan or ideological identity.


I hadn't looked for a while, but Harris was out raising and out spending Trump substantially when I'd last read up on it. Much of that seemed to come primarily from big donors.

Sure the more of the top richest people may have donated more to Trump or Republicans, but Harris raised much more overall.

https://www.forbes.com/sites/alisondurkee/2024/11/04/trump-v...

Seems like they both raised about the same from their top 20 largest donors:

> The Harris campaign received significantly more funding than Trump's, outspending the Republican advertising machine by more than 70 percent in the final stretch of the election.

> According to data from Open Secrets, Harris received almost $400 million from her 20 largest backers. Trump received over half a billion dollars from his top 20, which included over $100 million from SpaceX, Elon Musk's rocket company.

https://www.forbes.com/sites/alisondurkee/2024/11/04/trump-v...

My take of that is that Trump raised a bit more from concentrated donations from the richest billionaires, but Harris overall raised more from larger numbers of billionaires and millionaires.


Guidelines | FAQ | Lists | API | Security | Legal | Apply to YC | Contact

Search: